These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12182059)

  • 21. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.
    Machens A; Holzhausen HJ; Dralle H
    Cancer; 2005 Jun; 103(11):2269-73. PubMed ID: 15856429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Desperate search for a magic marker in difficult encapsulated follicular thyroid tumors].
    Franc B
    Ann Pathol; 2003 Feb; 23(1):7-10. PubMed ID: 12743495
    [No Abstract]   [Full Text] [Related]  

  • 24. Follicular thyroid lesions, elements that affect both diagnosis and prognosis.
    Zeiger MA; Dackiw AP
    J Surg Oncol; 2005 Mar; 89(3):108-13. PubMed ID: 15719377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Differentiated thyroid carcinoma of follicular origin: new data in 1988].
    De Micco C
    Arch Anat Cytol Pathol; 1989; 37(1-2):21-8. PubMed ID: 2649019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Geographic differences in iodine supply in the Silesia terrain in relation to thyroid cancer risk].
    Szpak S; Zeman M; Handkiewicz-Junak D; Kochańska-Dziurowicz A; Kurzeja E; Stanjek A; Bijak A; Bogacz A; Zemła B
    Wiad Lek; 2001; 54 Suppl 1():169-75. PubMed ID: 12182022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.
    Kim ES; Kim TY; Koh JM; Kim YI; Hong SJ; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):145-8. PubMed ID: 15212657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary cancer of the thyroid: natural history and therapy principles].
    Veroux P; Fazzi C; Nicosia AS; Veroux M; Cannizzaro MA
    Chir Ital; 1997; 49(1-2):15-27. PubMed ID: 12743871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathohistologic procedures in encapsulated follicular tumors of the thyroid gland].
    Separović V; Kruslin B; Kosanović S; Knezević F; Sarcević B; Danilović Z
    Lijec Vjesn; 1996; 118(5-6):138-41. PubMed ID: 8965625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic mutations in thyroid carcinoma.
    Taccaliti A; Boscaro M
    Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unusual tumors of the thyroid gland.
    Baloch ZW; LiVolsi VA
    Endocrinol Metab Clin North Am; 2008 Jun; 37(2):297-310, vii. PubMed ID: 18502328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
    Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
    Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma.
    Wang JX; Yu JK; Wang L; Liu QL; Zhang J; Zheng S
    Proteomics; 2006 Oct; 6(19):5344-9. PubMed ID: 16941571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular Thyroid Carcinoma: How Have Histologic Diagnoses Changed in the Last Half-Century and What Are the Prognostic Implications?
    Cipriani NA; Nagar S; Kaplan SP; White MG; Antic T; Sadow PM; Aschebrook-Kilfoy B; Angelos P; Kaplan EL; Grogan RH
    Thyroid; 2015 Nov; 25(11):1209-16. PubMed ID: 26440366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
    Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
    Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers?
    Letsas KP; Vartholomatos G; Tsepi C; Tsatsoulis A; Frangou-Lazaridis M
    Neoplasma; 2007; 54(1):57-62. PubMed ID: 17203893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel node biopsy for follicular tumours of the thyroid gland.
    Takeyama H; Tabei I; Uchida K; Morikawa T
    Br J Surg; 2009 May; 96(5):490-5. PubMed ID: 19358183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.